VivoSim Labs, Inc. (VIVS)
0.1561
+0.01
(+7.14%)
USD |
NASDAQ |
Oct 29, 16:00
0.153
0.00 (0.00%)
After-Hours: 20:00
VivoSim Labs Net Income (Quarterly) : -1.338M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.338M |
| March 31, 2026 | -5.764M |
| December 31, 2025 | -2.691M |
| September 30, 2025 | -2.545M |
| June 30, 2025 | -2.843M |
| March 31, 2025 | 6.852M |
| December 31, 2024 | -3.447M |
| September 30, 2024 | -2.549M |
| June 30, 2024 | -3.344M |
| March 31, 2024 | -3.045M |
| December 31, 2023 | -3.604M |
| September 30, 2023 | -3.994M |
| June 30, 2023 | -4.028M |
| March 31, 2023 | -7.459M |
| December 31, 2022 | -3.264M |
| September 30, 2022 | -3.321M |
| June 30, 2022 | -3.215M |
| March 31, 2022 | -1.911M |
| December 31, 2021 | -3.50M |
| September 30, 2021 | -3.505M |
| June 30, 2021 | -2.532M |
| March 31, 2021 | -2.596M |
| December 31, 2020 | -2.511M |
| September 30, 2020 | -8.95M |
| June 30, 2020 | -2.769M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.723M |
| December 31, 2019 | -3.37M |
| September 30, 2019 | -6.294M |
| June 30, 2019 | -6.323M |
| March 31, 2019 | -6.983M |
| December 31, 2018 | -6.399M |
| September 30, 2018 | -5.837M |
| June 30, 2018 | -7.416M |
| March 31, 2018 | -7.449M |
| December 31, 2017 | -7.791M |
| September 30, 2017 | -9.461M |
| June 30, 2017 | -10.10M |
| March 31, 2017 | -10.66M |
| December 31, 2016 | -9.581M |
| September 30, 2016 | -9.442M |
| June 30, 2016 | -8.767M |
| March 31, 2016 | -8.372M |
| December 31, 2015 | -10.46M |
| September 30, 2015 | -11.26M |
| June 30, 2015 | -8.491M |
| March 31, 2015 | -7.798M |
| December 31, 2014 | -6.993M |
| September 30, 2014 | -8.858M |
| June 30, 2014 | -6.433M |
| March 31, 2014 | -6.482M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 2.375B |
| Anika Therapeutics, Inc. | 3.309M |
| BioCryst Pharmaceuticals, Inc. | 78.40M |
| Imunon, Inc. | -2.814M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.018M |
| Total Expenses (Quarterly) | 1.356M |
| EPS Diluted (Quarterly) | -0.2554 |
| Enterprise Value | -0.8886M |
| Gross Profit Margin (Quarterly) | -122.2% |
| Profit Margin (Quarterly) | -7.43K% |
| Earnings Yield | -2.86K% |
| Normalized Earnings Yield | -2984.43 |